文献速递肝病

使用终末期肝病模型定义酒精相关性肝病的风险

Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.
PubMed 文献 · Am J Gastroenterol · 2025-07-17

WALDO回顾性队列纳入734例活检证实的酒精相关性肝病患者,中位随访4.9年,240例死于肝病或接受肝移植,114例死于非肝原因;MELD是结局的最佳预测指标(1年死亡/肝移植AUC 0.853),MELD3.0与Child-Turcotte-Pugh评分表现相似,基于MELD的风险估计在外部队列中校准良好。

要点

  • 失代偿期肝硬化或酒精性肝炎患者肝相关死亡或肝移植的累积发生率分别为47%和40%。
  • 无肝硬化患者肝相关死亡或肝移植的累积发生率为7.4%,代偿期肝硬化为13%。
  • MELD是结局的最佳预测指标,1年死亡/肝移植的AUC为0.853。

核心结论

  • 这些数据展示了酒精相关性肝病的自然史,并定义了不同疾病谱下基于MELD评分的结局风险。

研究设计与样本

  • WALDO回顾性队列纳入734例活检证实的酒精相关性肝病患者,使用动态AUC和C-index评估预后评分,并在外部队列中验证MELD的风险估计。

主要发现

  • 中位随访4.9年,240例患者死于肝病或接受肝移植,114例患者死于非肝原因。
  • 失代偿期肝硬化或酒精性肝炎患者肝相关死亡或肝移植的累积发生率分别为47%和40%。
  • 无肝硬化患者肝相关死亡或肝移植的累积发生率为7.4%,代偿期肝硬化为13%。
  • MELD是结局的最佳预测指标,1年死亡/肝移植的AUC为0.853;MELD3.0和Child-Turcotte-Pugh评分表现相似。
  • 基于MELD的风险估计在外部队列中校准良好。

关键数值与推荐

  • MELD评分整数对应的肝相关结局风险已制表。
  • 1年死亡/肝移植的AUC为0.853(MELD)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Alcohol-associated liver disease (ALD) is a common cause of morbidity and premature mortality. Most prognostic scores have been defined in the short term. We used a large retrospective cohort of patients with ALD to describe the natural history of ALD and to define risk prediction in the longer term, taking nonliver mortality into account. METHODS: The WALDO cohort includes 734 patients with biopsy-proven ALD. Prognostic scores were assessed with dynamic area under the curve and C-index. Risk estimates for morbidity and mortality were derived for the model for end-stage liver disease (MELD) and validated in an external cohort. RESULTS: During a median follow-up of 4.9 years, 240 patients died from liver disease or underwent liver transplantation (LT), and 114 patients died from nonliver causes. Outcomes varied across the spectrum of ALD: The cumulative incidence of liver-related death or LT in people with decompensated cirrhosis or alcohol-associated hepatitis was 47% and 40%, respectively, compared with 7.4% in patients without cirrhosis and 13% in compensated cirrhosis. MELD was the best predictor of outcomes: (area under the curve for mortality/LT at 1 year was 0.853), although MELD3.0 and the Child-Turcotte-Pugh score performed similarly. Risk of liver-related outcomes were tabulated for integer values of the MELD score. Risk estimates based on the MELD were well calibrated in an external cohort. DISCUSSION: These data illustrate the natural history of ALD and define the risks of outcomes based on the MELD score across the spectrum of disease.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Parker R, Aithal G, Allison M, et al. Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease. Am J Gastroenterol. 2025. PMID: 40673932. doi:10.14309/ajg.0000000000003649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。